PainReform (PRFX)

• Market cap: $2.27M
• 1 day: 7.62%
• 5 days: -10.32%
• 1 month: -18.71%
• 3 months: -16.3%
• 6 months: -50.66%
• Year to date: -65.12%
• 1 year: -42.93%
• 5 years: -99.9%
• 10 years: -99.93%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Employees: 6